SIRT2-IN-13
Product Specifications
UNSPSC Description
SIRT2-IN-13 (compound 7c) is an inhibitor of SIRT2 and induces apoptosis. SIRT2-IN-13 selectively inhibits colon cancer and leukemia cells and arrests the cell cycle in the G2 phase[1].
Target Antigen
Apoptosis; Sirtuin
Type
Reference compound
Related Pathways
Apoptosis;Cell Cycle/DNA Damage;Epigenetics
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/sirt2-in-13.html
Solubility
10 mM in DMSO
Smiles
CN(C)C1=CC(CNCCSC2(C3=CC=CC=C3)C4=C(C=CC=C4)C=CC5=C2C=CC=C5)=NC=C1
Molecular Weight
477.66
References & Citations
[1]Badran MM, et al. Ligand-based design and synthesis of new trityl histamine and trityl cysteamine derivatives as SIRT2 inhibitors for cancer therapy. Eur J Med Chem. 2024 Mar 7;269:116302.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161339/SIRT2-IN-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161339/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-89751JF549 0.1 mL
Rabbit Monoclonal CD8 beta Antibody (039) [Janelia Fluor 549]
Ask
View Details NBP2-12123AF405 0.1 mL
Rat Monoclonal CCL8/MCP-2 Antibody (RM0184-17A2) [Alexa Fluor 405]
Ask
View Details